Cited by 11Genomic variations and chromosomal abnormalitiesNicotinic Acetylcholine Receptors StudySchizophrenia research and treatment

CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents

Open access
Gillentine, Madelyn A., White, Janson J., Grochowski, Christopher M., Lupski, James R., Schaaf, Christian P., Calarge, Chadi A.·2017·Journal of Child and Adolescent Psychopharmacology

Abstract

OBJECTIVE: Aggression is among the most common indications for referral to child and adolescent mental health services and is often challenging to treat. Understanding the biological underpinnings of aggression could help optimize treatment efficacy. Neuronal nicotinic acetylcholine receptors (nAChRs), specifically the α7 nAChR, encoded by the gene CHRNA7, have been implicated in aggressive behaviors in animal models as well as humans. Copy number variants (CNVs) of CHRNA7 are found in individuals with neuropsychiatric disorders, often with comorbid aggression. In this study, we aimed to determine the prevalence of CHRNA7 CNVs among individuals treated with risperidone, predominantly for irritability and aggression. METHODS: Risperidone-treated children and adolescents were assessed for CHRNA7 copy number state using droplet digital PCR and genomic quantitative PCR. Demographic, anthropometric, and clinical data, including the Child Behavior Checklist (CBCL), were collected and compared across individuals with and without the CHRNA7 deletion. RESULTS: Of 218 individuals (90% males, mean age: 12.3 ± 2.3 years), 7 (3.2%) were found to carry a CHRNA7 deletion and one proband carried a CHRNA7 duplication (0.46%). T-scores for rule breaking, aggression, and externalizing behavior factors of the CBCL were higher in the deletion group, despite taking 58% higher dose of risperidone. CONCLUSIONS: CHRNA7 loss may contribute to a phenotype of severe aggression. Given the high prevalence of the deletion among risperidone-treated youth, future studies should examine the therapeutic potential of α7 nAChR-targeting drugs to target aggression associated with CHRNA7 deletions.

Integrity signals

Registry

Crossref · 10.1089/cap.2017.0068

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CHRNA7 deletion probands had significantly higher T scores than copy-neutral probands, even after accounting for age, sex, and weight-adjusted dose of risperidone and psychostimulants (b = 13.7, SE = 6.4, Cohen's d = 1.26, p = 0.0340 for aggression).

    “CHRNA7 dedeletion probands had significantly higher T scores than copy-neutral probands, even after accounting for age, sex, and weight-adjusted dose of risperidone and psychostimulants (b = 13.7, SE = 6.4, Cohen’s d = 1.26, p = 0.0340 for aggression)”

    From Genetics of child aggression, a systematic review (2024) · cites this paper as Gillentine [166]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gillentine, M. A., White, J. J., Grochowski, C. M., Lupski, J. R., Schaaf, C. P., & Calarge, C. A.
Affiliations
Baylor College of Medicine (US)
Corresponding author
  • Schaaf, Christian P.
  • Calarge, Chadi A.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2017-12
Volume
27
Issue
10
Pages
908-915
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2745482835
Cited by
11
References
35
Citations by year
2026: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 1
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • Journal of Child and Adolescent Psychopharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of General Medical Sciences (T32GM008307)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
CHRNA7, copy number variation, alpha7 nicotinic acetylcholine receptor, aggression, irritability, risperidone, children and adolescents, externalizing problems, rule violations, antipsychotic drugs
MeSH terms
Adolescent, Child, Female, Humans, Male, Prospective Studies, Antipsychotic Agents, Cohort Studies, Treatment Outcome, Gene Deletion, Risperidone, alpha7 Nicotinic Acetylcholine Receptor, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review